Rhythm Pharmaceuticals - M&A Summary and Business Overview

Medical ProductsCompany

Rhythm Pharmaceuticals M&A Summary

Rhythm Pharmaceuticals has acquired 2 companies, including 1 in the last 5 years. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2014, when it sold Motus Therapeutics to Allergan for $40M. Rhythm Pharmaceuticals has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

Rhythm Pharmaceuticals Business Overview

Where is Rhythm Pharmaceuticals headquartered?

Rhythm Pharmaceuticals is headquartered in Boston, Massachusetts.

What sector is Rhythm Pharmaceuticals in?

Rhythm Pharmaceuticals is a medical products company.

When was Rhythm Pharmaceuticals founded?

Rhythm Pharmaceuticals was founded in 2008.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity2
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 2

Rhythm Pharmaceuticals, Inc.

855 Boylston Street 11th Floor,
Boston, Massachusetts 02116
United States,
(857)264-4280
www.rhythmtx.com

Rhythm is a biopharmaceutical company developing peptide therapeutics that address unmet needs in gastrointestinal diseases and obesity, including obesity caused by genetic deficiencies in the MC4 pathway.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 1 - - - 1 - 2
Sell (0.0/yr) # 1 - - - - - 1
vol $40M $40M
  3

Most Recent M&A

Company Date Value Type
Xinvento B.V. 2023-02-27 - Add-on Acquisition
Amsterdam, Netherlands · www.xinvento.com
Motus Therapeutics, Inc. 2016-10-27 - Divestiture
Boston, United States · www.motustx.com
Motus Therapeutics, Inc. 2014-10-22 40M USD Divestiture
Boston, United States · www.motustx.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) - 1 (100%) 40M (100%)
Total 2 - 1 $40M

By Geo

State/Country Buy Value Sell Value
United States 1 - 1 40M
Netherlands 1 - - -
Domestic 1 (50%) - 1 (100%) 40M (100%)
Cross-border 1 (50%) - - -
Total 2 - 1 $40M

Deal Values

sell # Total
< $100M 1 $40M
TOTAL $40M
Largest Motus Therapeutics, Inc.
$40M (2014-10-22)

M&A Connections

Deals
Acquired from
Strategic(s)
50%
1 (50%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.